CorMedix Community

Key Takeaways Expansion into new patient populations and broader hospital adoption are set to drive recurring revenues, improved margins, and long-term earnings stability. Real-world outcomes data and potential orphan drug status could enable premium pricing and stronger insurance reimbursement advantages.